Metronidazole 500 mg / 100 ml Intravenous Infusion clinical trials

C3601010: A Phase 2A, 2-Part, Open-Label, Non-Randomized, Multicenter, Single and Multiple Dose Trial to Evaluate Pharmacokinetics, Safety and Tolerability of Aztreonam and Avibactam ± Metronidazole in Neonates and Infants From Birth to Less Than 9 Months of Age With Suspected or Confirmed Infections Due to Gram-Negative Pathogens Requiring Intravenous Antibiotic Treatment

This study is testing a new combination antibiotic treatment (Aztreonam and Avibactam, sometimes with Metronidazole) for serious bacterial infections in babies up to 9 months old. It aims to see how the medicines work in their bodies and if they are safe.